Octaplas (Octapharma USA Inc)
Welcome to the PulseAid listing for the Octaplas drug offered from Octapharma USA Inc. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | Octapharma USA Inc |
| NON-PROPRIETARY NAME: | human plasma proteins |
| SUBSTANCE NAME: | PLASMA PROTEIN FRACTION (HUMAN) |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2013-07-18 |
| END MARKETING DATE: | 0000-00-00 |
Octaplas PLASMA DERIVATIVE Details:
| Item Description | Octaplas from Octapharma USA Inc |
| LABELER NAME: | Octapharma USA Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 11.5(g/200mL) |
| START MARKETING DATE: | 2013-07-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68982-952_31e0d6f1-df02-0b01-2995-af88f7fbc523 |
| PRODUCT NDC: | 68982-952 |
| APPLICATION NUMBER: | BLA125416 |
Other PLASMA PROTEIN FRACTION (HUMAN) Pharmaceutical Manufacturers / Labelers:
